Showing results (1211-1220 of 2,812) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|August 23, 2014
Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancerBrittany Anne Davidson, Patricia G MoormanExpert Opinion on Drug Safety|August 24, 2014
Safety of ACE inhibitor therapies in patients with chronic kidney diseaseGrigory Sidorenkov, Gerjan NavisExpert Opinion on Drug Safety|November 4, 2014
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancerThor Chalmer, Thomas P Almdal, Tina Vilsbøll, et al.Expert Opinion on Drug Safety|November 11, 2014
Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smokingTineke Vandenbroucke, Magali Verheecke, Kristel Van Calsteren, et al.Expert Opinion on Drug Safety|June 17, 2016
Faster drug approval: challenges for safetyPaolo PreziosiExpert Opinion on Drug Safety|July 2, 2016
The safety of pharmacologic options for the treatment of persons with hemophiliaMassimo Franchini, Pier Mannuccio MannucciExpert Opinion on Drug Safety|June 15, 2016
The safety of vandetanib for the treatment of thyroid cancerVenessa H M Tsang, Bruce G Robinson, Diana L LearoydExpert Opinion on Drug Safety|March 17, 2016
The safety of monoclonal antibodies for treatment of colorectal cancerMartin D Berger, Heinz-Josef LenzExpert Opinion on Drug Safety|March 18, 2016
Adverse events following immunization: real causality and mythsNicola Principi, Susanna EspositoExpert Opinion on Drug Safety|March 19, 2016
Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessmentBenjamin Rolland, Marine Auffret, Nicolas FranchittoPageof 282